ARTiFACTS
Healthcare Software · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.artifacts.aiRevenue
<$5 MillionIndustry
About ARTiFACTS
ARTiFACTS Org Chart
Is ARTiFACTS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ARTiFACTS launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ARTiFACTS is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ARTiFACTS
Funding: Get notified immidiatlly once ARTiFACTS has new funding data
Earning: See what the market has to say on ARTiFACTS recently announced quarterly report
Click to see if ARTiFACTS had a recent Job posting/layoffs
ARTiFACTS, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ARTiFACTS has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to ARTiFACTS
Compare insights from companies similar to ARTiFACTS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ARTiFACTS is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
ARTiFACTS is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about ARTiFACTS.
ARTiFACTS Tech Stack
A closer look at the technologies used by ARTiFACTS
ARTiFACTS News & Media
Version 2 of ARTIFACTS.ai groundbreaking platform accelerates secure disclosure of research findings
BOSTON, July 30, 2020 /PRNewswire/ -- ARTiFACTS today released Version 2.0 of their platform. This major upgrade enables researchers to establish the provenance of their work in real-time — making it accessible and citable before publication. Utilizing the bloxberg blockchain ledger from...Partners in Digital Health launches Blockchain based Ledger of Record for Research in Collaboration with ARTiFACTS
We are pleased to announce the world's first life science research portal for authors and global communities of the peer review journals Blockchain in Healthcare Today (BHTY) and Telehealth and Medicine Today (TMT). The newly launched portal will register each original research article's provenance on the blockchain for every author to create a permanent and immutable public record of their work on the blockchain for the scientific community. - - The PDH+ARTiFACTS&nImageRights Announces New Appointments To Advisory Board
Bruce Stangle And Kevin McCurry To Counsel On Market Strategy And Corporate Initiatives (PRWeb August 09, 2018) Read the full story at https://www.prweb.com/releases/imagerights_announces_new_appointments_to_advisory_board/prweb15680615.htmBreakthrough Telehealth and Medicine Today Health Innovation Journal Launches on Open Source Platform -
Partners in Digital Health has relaunched the Telehealth and Medicine Today (TMT) journal on the Open Journal System (OJS) platform. “Since TMT's last issue, we have taken the journal to an open source platform adding features reflecting TMT's leading-edge reputation in the sector. We continue to push the envelope in scholarly publishing with our mission in a market that now accepts telehealth and medicine as the path to a re-imagined health system, stated Ms. Tory
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARTiFACTS
ARTiFACTS offers a post-market surveillance system called VERIFY, which utilizes chemical analysis, artificial intelligence, and blockchain technology to detect and report counterfeit medicines. The company addresses the global challenge of substandard and falsified drugs, which pose significant risks to public health and patient safety. Their solu... Read More